CN Patent

CN107875122A — 一种盐酸鲁拉西酮自微乳制剂及其制备方法

Assigned to Foshan Hongtai Pharmaceutical Development Co Ltd · Expires 2018-04-06 · 8y expired

What this patent protects

本发明公开了一种盐酸鲁拉西酮自微乳制剂及其制备方法，其是将盐酸鲁拉西酮、油相、乳化剂、助乳化剂组成液体自微乳制剂，或将所得液体自微乳制剂进一步与赋形剂制成固体自微乳制剂。

USPTO Abstract

本发明公开了一种盐酸鲁拉西酮自微乳制剂及其制备方法，其是将盐酸鲁拉西酮、油相、乳化剂、助乳化剂组成液体自微乳制剂，或将所得液体自微乳制剂进一步与赋形剂制成固体自微乳制剂。

Drugs covered by this patent

lurasidone-hydrochloride (LURASIDONE HYDROCHLORIDE)

Patent Metadata

Patent number: CN107875122A
Jurisdiction: CN
Classification: —
Expires: 2018-04-06
Drug substance claim: No
Drug product claim: No
Assignee: Foshan Hongtai Pharmaceutical Development Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.